News and Trends 11 Feb 2015
AB Science: One step further towards a cure to Alzheimer’s disease
AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors (PKIs), today announced the successful completion of a futility analysis related to the masitinib phase 3 trial for the treatment of mild to moderate Alzheimer’s disease. Today, between 5 and 10 million people suffer from Alzheimer’s disease in the USA […]
